Unified agenda: FDA publishes lengthy to-do list

Unified agenda: FDA publishes lengthy to-do list

Source: 
RAPS.org
snippet: 

Two final rules top the Spring 2020 regulatory agenda for the US Food and Drug Administration (FDA), addressing the importation of prescription drugs and the de novo classification process for medical devices. The agency’s unified agenda overall is mammoth and includes 26 final rules as well as 52 proposed rules, some of which have been carried over from previous agendas.